Compare INNV & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INNV | BVS |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 485.4M | 508.4M |
| IPO Year | 2021 | 2021 |
| Metric | INNV | BVS |
|---|---|---|
| Price | $5.56 | $7.40 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $5.00 | ★ $13.50 |
| AVG Volume (30 Days) | 177.1K | ★ 277.3K |
| Earning Date | 02-03-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.15 |
| Revenue | ★ $884,662,000.00 | $563,829,000.00 |
| Revenue This Year | $11.18 | N/A |
| Revenue Next Year | $9.58 | $7.11 |
| P/E Ratio | ★ N/A | $48.57 |
| Revenue Growth | ★ 12.48 | 1.58 |
| 52 Week Low | $2.60 | $5.81 |
| 52 Week High | $6.26 | $11.25 |
| Indicator | INNV | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 52.98 | 50.09 |
| Support Level | $5.66 | $7.26 |
| Resistance Level | $6.10 | $7.71 |
| Average True Range (ATR) | 0.37 | 0.26 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 60.69 | 44.75 |
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.